Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Perception of AL-4943A in Allergic Conjunctivitis
NCT01294969Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olopatadine in allergic conjunctivitis (AC), sponsored by Alcon Inc.. Started Sep 2010; status: completed.
02
Drugs
olopatadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01294969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294969.